September 14, 2018 / 7:24 AM / 2 months ago

Takeda gets China's approval for $62 bln Shire purchase

Sept 14 (Reuters) - Japan’s Takeda Pharmaceutical Co Ltd said on Friday China’s market regulator had approved its $62 billion acquisition of Shire Plc, bringing it closer to becoming a global top 10 drugmaker.

The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the United States and Brazil. (Reporting by Shashwat Awasthi in Bengaluru; Editing by Sai Sachin Ravikumar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below